Literature DB >> 14603265

Gene expression profiling of depression and suicide in human prefrontal cortex.

Etienne Sibille1, Victoria Arango, Hanga C Galfalvy, Paul Pavlidis, Loubna Erraji-Benchekroun, Steve P Ellis, J John Mann.   

Abstract

Mood disorders are a major cause of disability. Etiology includes genetic and environmental factors, but the responsible genes have yet to be identified. Using DNA microarrays, we have conducted a large-scale gene expression analysis, in two regions of the human prefrontal cortex from post-mortem matched groups of subjects with major depression who had died by suicide, and control subjects who died from other causes and were free from psychiatric disorders. Bioinformatic analysis was used to investigate molecular and cellular pathways potentially involved in depression and suicidal behavior. We tested several hypotheses of disease pathology and of their putative molecular impact, including changes in single genes, the existence of subgroups of patients or disease subtypes, or the possibility of common biological pathways being affected in the disease process. Within the analytical limits of this relatively large genomic study, we found no evidence for molecular differences that correlated with depression and suicide, suggesting a pathology that is below the detection level of current genomic approaches, or that is either localized to other brain areas, or more associated with post-transcriptional effects and/or changes in protein levels or functions, rather than altered transcriptome in the prefrontal cortex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14603265     DOI: 10.1038/sj.npp.1300335

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  44 in total

1.  Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.

Authors:  M P Vawter; H Tomita; F Meng; B Bolstad; J Li; S Evans; P Choudary; M Atz; L Shao; C Neal; D M Walsh; M Burmeister; T Speed; R Myers; E G Jones; S J Watson; H Akil; W E Bunney
Journal:  Mol Psychiatry       Date:  2006-04-25       Impact factor: 15.992

Review 2.  Gene expression profiling of the brain: pondering facts and fiction.

Authors:  Amanda C Mitchell; Károly Mirnics
Journal:  Neurobiol Dis       Date:  2011-06-14       Impact factor: 5.996

3.  The Role of Dendritic Brain-Derived Neurotrophic Factor Transcripts on Altered Inhibitory Circuitry in Depression.

Authors:  Hyunjung Oh; Sean C Piantadosi; Brad R Rocco; David A Lewis; Simon C Watkins; Etienne Sibille
Journal:  Biol Psychiatry       Date:  2018-10-09       Impact factor: 13.382

4.  A molecular signature of depression in the amygdala.

Authors:  Etienne Sibille; Yingjie Wang; Jennifer Joeyen-Waldorf; Chris Gaiteri; Alexandre Surget; Sunghee Oh; Catherine Belzung; George C Tseng; David A Lewis
Journal:  Am J Psychiatry       Date:  2009-07-15       Impact factor: 18.112

5.  Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression.

Authors:  Chris Gaiteri; Jean-Philippe Guilloux; David A Lewis; Etienne Sibille
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

6.  Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression.

Authors:  Adolfo Sequeira; Firoza Mamdani; Carl Ernst; Marquis P Vawter; William E Bunney; Veronique Lebel; Sonia Rehal; Tim Klempan; Alain Gratton; Chawki Benkelfat; Guy A Rouleau; Naguib Mechawar; Gustavo Turecki
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

7.  Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression.

Authors:  R C Shelton; J Claiborne; M Sidoryk-Wegrzynowicz; R Reddy; M Aschner; D A Lewis; K Mirnics
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

8.  Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders.

Authors:  Hanna E Stevens; Karen M Smith; Brian G Rash; Flora M Vaccarino
Journal:  Front Neurosci       Date:  2010-09-01       Impact factor: 4.677

9.  The role of proteomics in depression research.

Authors:  Daniel Martins-de-Souza; Laura W Harris; Paul C Guest; Christoph W Turck; Sabine Bahn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-09       Impact factor: 5.270

Review 10.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.